Patrick Anquetil, CEO of Portal Instruments, shared insights with Startup.Info on how Portal Instruments, a needle-free drug delivery company has adapted, remained healthy, and made progress during the pandemic. “We realized early on that this would be a serious crisis and prepared ourselves to shut down the company office quickly. We sent our engineers home with what they needed and they set-up home laboratories and testing facilities. Being flexible allowed us to go 100% remote without skipping a beat.”  Read the full article here.

Portal’s platform is in development and not available for sale or use.